Top

Published in:

01-06-2021 | Parkinson's Disease | Original Paper

The Role of lncRNA TUG1 in the Parkinson Disease and Its Effect on Microglial Inflammatory Response

Authors: Jiang Cheng, Yangyang Duan, Fengting Zhang, Jin Shi, Hui Li, Feng Wang, Haining Li

Published in: NeuroMolecular Medicine | Issue 2/2021

Abstract

Parkinson’s disease (PD) is a common neurodegenerative disease in the middle-aged and elderly populations. The purpose of this study was to investigate the clinical value of lncRNA TUG1 in PD and its effect on the microglial inflammatory response. A total of 181 subjects were recruited for the study, including 97 patients with PD (male/female 50/47) and 84 healthy individuals (male/female 41/43). There was no significant difference for gender and age distribution between the groups. The expression of serum TUG1 was determined by qRT-PCR. The receiver operating curve (ROC) was applied for diagnostic value analysis. CCK-8 was used to detect the effect of TUG1 on the proliferation of BV2 cells. The motor coordination ability of mice was tested by the rotarod and pole tests. ELISA was used to detect serum pro-inflammatory factors. TUG1 was highly expressed in the serum of PD patients. Serum TUG1 can distinguish PD patients to form healthy controls with the AUC of 0.902. Serum TUG1 was positively correlated with the levels of UPDRS, IL-6, IL-1β, and TNF-α in PD patients. Cell experiment results showed that the downregulation of TUG1 significantly inhibited cell proliferation and the release of TNF-α, IL-6, and IL-1β. Besides, animal experiments suggested that the downregulation of TUG1 significantly improved the motor coordination ability of the PD mice and inhibited the expression of inflammatory factors. lncRNA TUG1 is a latent biomarker of PD patients. TUG1 downregulation may inhibit the inflammatory response in the progression of PD. These findings provide a possible target for the early diagnosis and therapeutic intervention of PD.

Bachiller, S., Jimenez-Ferrer, I., Paulus, A., Yang, Y., Swanberg, M., Deierborg, T., et al. (2018). Microglia in neurological diseases: A road map to brain-disease dependent-inflammatory response. Frontiers in Cellular Neuroscience, 12, 488. https://doi.org/10.3389/fncel.2018.00488CrossRefPubMedPubMedCentral

Bagyinszky, E., Giau, V. V., & An, S. A. (2020). Transcriptomics in Alzheimer’s disease: Aspects and challenges. International Journal of Molecular Sciences, 21(10), 3517. https://doi.org/10.3390/ijms21103517CrossRefPubMedCentral

Chen, H. X., Liang, F. C., Gu, P., Xu, B. L., Xu, H. J., Wang, W. T., et al. (2020). Exosomes derived from mesenchymal stem cells repair a Parkinson’s disease model by inducing autophagy. Cell Death & Disease, 11(4), 288. https://doi.org/10.1038/s41419-020-2473-5CrossRef

Chen, W., Xu, Z. M., Wang, G., & Chen, S. D. (2012). Non-motor symptoms of Parkinson’s disease in China: A review of the literature. Parkinsonism & Related Disorders, 18(5), 446–452. https://doi.org/10.1016/j.parkreldis.2012.02.002CrossRef

Derrien, T., Johnson, R., Bussotti, G., Tanzer, A., Djebali, S., Tilgner, H., et al. (2012). The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression. Genome Research, 22(9), 1775–1789. https://doi.org/10.1101/gr.132159.111CrossRefPubMedPubMedCentral

Fang, W., Gao, G., Zhao, H., Xia, Y., Guo, X., Li, N., et al. (2015). Role of the Akt/GSK-3beta/CRMP-2 pathway in axon degeneration of dopaminergic neurons resulting from MPP+ toxicity. Brain Research, 1602, 9–19. https://doi.org/10.1016/j.brainres.2014.08.030CrossRefPubMed

Fu, C., Chen, J., Lu, J., Pei, S., Hu, S., Jiang, L., et al. (2019). Downregulation of TUG1 promotes melanogenesis and UVB-induced melanogenesis. Experimental Dermatology, 28(6), 730–733. https://doi.org/10.1111/exd.13929CrossRefPubMed

Han, Y., Liu, Y., Gui, Y., & Cai, Z. (2013). Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder. Journal of Surgical Oncology, 107(5), 555–559. https://doi.org/10.1002/jso.23264CrossRefPubMed

Horvath, I., Iashchishyn, I. A., Moskalenko, R. A., Wang, C., Warmlander, S., Wallin, C., et al. (2018). Co-aggregation of pro-inflammatory S100A9 with alpha-synuclein in Parkinson’s disease: Ex vivo and in vitro studies. Journal of Neuroinflammation, 15(1), 172. https://doi.org/10.1186/s12974-018-1210-9CrossRefPubMedPubMedCentral

Hugh-Jones, M. E., Peele, R. H., & Wilson, V. L. (2020). Parkinson’s disease in Louisiana, 1999–2012: Based on hospital primary discharge diagnoses, incidence, and risk in relation to local agricultural crops, pesticides, and aquifer recharge. International Journal of Environmental Research and Public Health, 17(5), 1584. https://doi.org/10.3390/ijerph17051584CrossRefPubMedCentral

Johnson, R. (2012). Long non-coding RNAs in Huntington’s disease neurodegeneration. Neurobiology of Diseases, 46(2), 245–254. https://doi.org/10.1016/j.nbd.2011.12.006CrossRef

Kim, H. W., Lee, H. S., Kang, J. M., Bae, S. H., Kim, C., Lee, S. H., et al. (2018). Dual effects of human placenta-derived neural cells on neuroprotection and the inhibition of neuroinflammation in a rodent model of Parkinson’s disease. Cell Transplantation, 27(5), 814–830. https://doi.org/10.1177/0963689718766324CrossRefPubMedPubMedCentral

Long, T., He, W., Pan, Q., Zhang, S., Zhang, D., Qin, G., et al. (2020). Microglia P2X4R-BDNF signalling contributes to central sensitization in a recurrent nitroglycerin-induced chronic migraine model. The Journal of Headache and Pain, 21(1), 4. https://doi.org/10.1186/s10194-019-1070-4CrossRefPubMedPubMedCentral

Mollenhauer, B., Zimmermann, J., Sixel-Doring, F., Focke, N. K., Wicke, T., Ebentheuer, J., et al. (2019). Baseline predictors for progression 4 years after Parkinson’s disease diagnosis in the De Novo Parkinson Cohort (DeNoPa). Movement Disorders, 34(1), 67–77. https://doi.org/10.1002/mds.27492CrossRefPubMed

Neves, K. R., Nobre, H. V., Jr., Leal, L. K., de Andrade, G. M., Brito, G. A., & Viana, G. S. (2015). Pentoxifylline neuroprotective effects are possibly related to its anti-inflammatory and TNF-alpha inhibitory properties, in the 6-OHDA model of Parkinson’s disease. Parkinsons Diseases, 2015, 108179. https://doi.org/10.1155/2015/108179CrossRef

Nolan, R., & Gaskill, P. J. (2019). The role of catecholamines in HIV neuropathogenesis. Brain Research, 1702, 54–73. https://doi.org/10.1016/j.brainres.2018.04.030CrossRefPubMed

Olmedillas Del Moral, M., Asavapanumas, N., Uzcategui, N. L., & Garaschuk, O. (2019). Healthy brain aging modifies microglial calcium signaling in vivo. International Journal of Molecular Sciences, 20(3), 589. https://doi.org/10.3390/ijms20030589CrossRefPubMedCentral

Santoro, M., Nociti, V., Lucchini, M., Loiodice, M., Centofanti, F., Botta, A., et al. (2020). A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients. European Review for Medical and Pharmacological Sciences, 24(6), 3267–3273. https://doi.org/10.26355/eurrev_202003_20694CrossRefPubMed

Seo, J., Jung, J., Jang, D. S., Kim, J., & Kim, J. H. (2017). Induction of cell death by betulinic acid through induction of apoptosis and inhibition of autophagic flux in microglia BV-2 cells. Biomolecules and Therapeutics (Seoul), 25(6), 618–624. https://doi.org/10.4062/biomolther.2016.255CrossRef

Wang, H., Liao, S., Li, H., Chen, Y., & Yu, J. (2019). Long non-coding RNA TUG1 sponges Mir-145a-5p to regulate microglial polarization after oxygen-glucose deprivation. Frontiers in Molecular Neuroscience, 12, 215. https://doi.org/10.3389/fnmol.2019.00215CrossRefPubMedPubMedCentral

Wang, X. S., Zhang, Z., Wang, H. C., Cai, J. L., Xu, Q. W., Li, M. Q., et al. (2006). Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clinical Cancer Research, 12(16), 4851–4858. https://doi.org/10.1158/1078-0432.CCR-06-0134CrossRefPubMed

Yamada, Y., Shinkawa, K., & Shimmei, K. (2020). Atypical repetition in daily conversation on different days for detecting Alzheimer disease: Evaluation of phone-call data from regular monitoring service. JMIR Mental Health, 7(1), e16790. https://doi.org/10.2196/16790CrossRefPubMedPubMedCentral

Ye, J., Sun, H., Feng, Z., Zhang, Q., Xia, Y., Ji, Y., et al. (2019). Prognostic significance of LncRNA GHET1 expression in various cancers: A systematic review and meta-analysis. Bioscience Reports. https://doi.org/10.1042/BSR20190608CrossRefPubMedPubMedCentral

Yin, D. D., Zhang, E. B., You, L. H., Wang, N., Wang, L. T., Jin, F. Y., et al. (2015). Downregulation of lncRNA TUG1 affects apoptosis and insulin secretion in mouse pancreatic beta cells. Cellular Physiology and Biochemistry, 35(5), 1892–1904. https://doi.org/10.1159/000373999CrossRefPubMed

Young, T. L., Matsuda, T., & Cepko, C. L. (2005). The noncoding RNA taurine upregulated gene 1 is required for differentiation of the murine retina. Current Biology, 15(6), 501–512. https://doi.org/10.1016/j.cub.2005.02.027CrossRefPubMed

Zhang, Q., Geng, P. L., Yin, P., Wang, X. L., Jia, J. P., & Yao, J. (2013). Down-regulation of long non-coding RNA TUG1 inhibits osteosarcoma cell proliferation and promotes apoptosis. Asian Pacific Journal of Cancer Prevention, 14(4), 2311–2315. https://doi.org/10.7314/apjcp.2013.14.4.2311CrossRefPubMed

Zhao, Z. H., Chen, Z. T., Zhou, R. L., Zhang, X., Ye, Q. Y., & Wang, Y. Z. (2018). Increased DJ-1 and alpha-synuclein in plasma neural-derived exosomes as potential markers for Parkinson’s disease. Frontiers in Aging Neuroscience, 10, 438. https://doi.org/10.3389/fnagi.2018.00438CrossRefPubMed

Title: The Role of lncRNA TUG1 in the Parkinson Disease and Its Effect on Microglial Inflammatory Response
Authors: Jiang Cheng
Yangyang Duan
Fengting Zhang
Jin Shi
Hui Li
Feng Wang
Haining Li
Publication date: 01-06-2021
Publisher: Springer US
Keyword: Parkinson's Disease
Published in: NeuroMolecular Medicine / Issue 2/2021
Print ISSN: 1535-1084
Electronic ISSN: 1559-1174
DOI: https://doi.org/10.1007/s12017-020-08626-y

At a glance: The STEP trials

Springer Medicine

The Role of lncRNA TUG1 in the Parkinson Disease and Its Effect on Microglial Inflammatory Response

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2021

Low Levels of LRRK2 Gene Expression are Associated with LRRK2 SNPs and Contribute to Parkinson’s Disease Progression

MiR-874 Inhibits Cell Proliferation, Migration, and Invasion of Glioma Cells and Correlates with Prognosis of Glioma Patients

Molecular Classification of Gliomas is Associated with Seizure Control: A Retrospective Analysis

The Gut Ecosystem: A Critical Player in Stroke

Galectin-9 Promotes Neuronal Restoration via Binding TLR-4 in a Rat Intracerebral Hemorrhage Model

Application of Next-Generation Sequencing in Neurodegenerative Diseases: Opportunities and Challenges